Company intelligence / Profile preview

Itero Biopharmaceuticals

Burlingame, California, USAprnewswire.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Itero Biopharmaceuticals focused on developing value-added follow-on and novel therapeutic proteins and antibodies. Its lead program was a recombinant follicle stimulating hormone (rFSH) biosimilar for the treatment of female infertility, which was licensed to Watson Pharmaceuticals while still in preclinical development. No clinical results have been published or reported.

Therapeutic areas: Women's Health
Modalities: Therapeutic proteinsMonoclonal antibodiesFusion proteins
Industry: Biotech

Drug pipeline

1 asset

recombinant follicle stimulating hormone

Pre-clinical

Indications: Female infertility

Partnerships

Watson Pharmaceuticals/Actavis plc – exclusive worldwide license agreement for rFSH product development and commercializationBiological E Limited – strategic collaboration for joint development/manufacturing of biotherapeutic products targeting global markets including US/EU approvals

Beyond the preview

Go deeper on Itero Biopharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Itero Biopharmaceuticals.

Explore the full profile